Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.verified

ACHV

Price:

$4.74

Market Cap:

$162.78M

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.[Read more]

Industry

Biotechnology

IPO Date

1995-10-12

Stock Exchange

NASDAQ

Ticker

ACHV

The Enterprise Value as of November 2024 (TTM) for Achieve Life Sciences, Inc. (ACHV) is 165.67M

According to Achieve Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 165.67M. This represents a change of 62.38% compared to the average of 102.02M of the last 4 quarters.

Achieve Life Sciences, Inc. (ACHV) Historical Enterprise Value (quarterly & annually)

How has ACHV Enterprise Value performed in the past?

The mean historical Enterprise Value of Achieve Life Sciences, Inc. over the last ten years is 10.19M. The current 165.67M Enterprise Value has changed 162.42% with respect to the historical average. Over the past ten years (40 quarters), ACHV's Enterprise Value was at its highest in in the June 2024 quarter at 166.93M. The Enterprise Value was at its lowest in in the December 2019 quarter at -10576844.60.

Quarterly (TTM)
Annual

Average

10.19M

Median

507.40K

Minimum

-13660837.10

Maximum

82.87M

Achieve Life Sciences, Inc. (ACHV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Achieve Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 376.83%

Maximum Annual Enterprise Value = 82.87M

Minimum Annual Increase = -864.57%

Minimum Annual Enterprise Value = -13660837.10

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202382.87M376.83%
202217.38M-14.06%
202120.22M-248.04%
2020-13660837.1014.49%
2019-11931408.00127.50%
2018-5244658.00-549.22%
20171.17M-864.57%
2016-152700.00-93.93%
2015-2515130.00-118.23%
201413.80M-87.74%

Achieve Life Sciences, Inc. (ACHV) Average Enterprise Value

How has ACHV Enterprise Value performed in the past?

The current Enterprise Value of Achieve Life Sciences, Inc. (ACHV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

40.16M

5-year avg

18.98M

10-year avg

10.19M

Achieve Life Sciences, Inc. (ACHV) Enterprise Value vs. Peers

How is ACHV’s Enterprise Value compared to its peers?

Achieve Life Sciences, Inc.’s Enterprise Value is less than VectivBio Holding AG (848.58M), less than Icosavax, Inc. (713.87M), less than Apellis Pharmaceuticals, Inc. (3.59B), greater than iTeos Therapeutics, Inc. (82.02M), greater than TScan Therapeutics, Inc. (116.95M), less than Day One Biopharmaceuticals, Inc. (1.07B), greater than Acumen Pharmaceuticals, Inc. (137.49M), greater than X4 Pharmaceuticals, Inc. (20.60M), less than Inozyme Pharma, Inc. (308.76M), greater than Immix Biopharma, Inc. (20.49M), greater than CNS Pharmaceuticals, Inc. (2.61M), greater than Hepion Pharmaceuticals, Inc. (1.72M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than AVROBIO, Inc. (-85302404.00), greater than NextCure, Inc. (21.96M), greater than CytomX Therapeutics, Inc. (47.40M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Spero Therapeutics, Inc. (11.13M), greater than Assembly Biosciences, Inc. (90.29M), greater than Bolt Biotherapeutics, Inc. (38.25M), less than Coherus BioSciences, Inc. (216.29M), less than Gracell Biotechnologies Inc. (5.47B),

Build a custom stock screener for Achieve Life Sciences, Inc. (ACHV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achieve Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achieve Life Sciences, Inc. (ACHV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achieve Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Achieve Life Sciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Achieve Life Sciences, Inc. (ACHV)?

What is the 3-year average Enterprise Value for Achieve Life Sciences, Inc. (ACHV)?

What is the 5-year average Enterprise Value for Achieve Life Sciences, Inc. (ACHV)?

How does the current Enterprise Value for Achieve Life Sciences, Inc. (ACHV) compare to its historical average?